LO News 60.17 07/16/2014 05:19:59 Lorillard Inc (LO)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Lorillard Inc (LO) 60.17 $LO

Goldman's Big Day and the Even Bigger Tobacco Merger
Jack Kramer and Nick Martell, The Motley Fool - Motley Fool - Tue Jul 15, 10:00PM CDT
Put on your classiest Vineyard Vines tie and shave that thing you call a beard. Tuesday was all about the quarterly earnings from America's two biggest branded banks -- and one hefty tobacco acquisition -- as the  Dow Jones Industrial Average ...

Apple Gains After Hours and Lorillard Tumbles
Jeremy Bowman, The Motley Fool - Motley Fool - Tue Jul 15, 9:00PM CDT
Stocks mostly fell today as Janet Yellen said she and other Federal Reserve bankers believed that some stock valuations in certain sectors had been "stretched." In a report accompanying her congressional testimony, Yellen called out social media and...

Harwood Feffer LLP Announces Investigation of Lorillard, Inc.
PR Newswire - Tue Jul 15, 8:00PM CDT
Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Lorillard, Inc. ("Lorillard" or the "Company" (NYSE: LO) concerning the proposed acquisition of the Company by R.J. Reynolds Tobacco Company ("R.J. Reynolds".

Reynolds American No Longer Blowing Smoke: It's Buying Lorillard
Rich Duprey, The Motley Fool - Motley Fool - Tue Jul 15, 7:14PM CDT
After months of speculation and rumor-mongering, Reynolds American announced that it's finally acquiring rival Lorillard in a cash-and-stock deal worth some $27.4 billion. The news comes just days after the two tobacco giants confirmed they...

Why Lorillard, Inc., Michael Kors Holdings Ltd., and Reynolds American Inc. Are Today's 3 Worst Stoc
John Divine, The Motley Fool - Motley Fool - Tue Jul 15, 6:38PM CDT
Two out of every three stocks lost ground today, as pressure applied by Federal Reserve Chairwoman Janet Yellen's testimony before Congress today was too much to bear. Although she indicated that interest rates would remain low into the foreseeable...

SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of Lorillard, Inc. In Connection With The Proposed Sale Of The Company
Business Wire - Tue Jul 15, 6:10PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the board of directors of Lorillard, Inc. ("Lorillard" or the "Company" (NYSE: LO) relating to the proposed buyout of the Company by Reynolds American Inc. ("Reynolds".

LORILLARD INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Lorillard, Inc. Board of Directors in Connection With the Proposed Sale of the Company to Reynolds American Inc.
Business Wire - Tue Jul 15, 6:00PM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Lorillard, Inc. ("Lorillard" or the "Company" (NYSE:LO) for potential breaches of fiduciary duties in connection with the sale of the Company to Reynolds American Inc. (NYSE:RAI) for approximately $27.4 billion. The Company's stockholders will only receive $50.50 cash and 0.2909 shares of Reynolds American common stock for each share of Lorillard common stock they own. This consideration only values Lorillard at approximately $68.88 per share.

Why Lorillard, Aaron's, and Michael Kors Tumbled Today
Dan Caplinger, The Motley Fool - Motley Fool - Tue Jul 15, 5:45PM CDT
Earnings season is in full force on Wall Street, and the impact on stocks thus far has generally been favorable. But today, even an opening round of favorable earnings wasn't enough to sustain gains throughout the day, as most major indexes posted...

LORILLARD INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lorillard, Inc.
PR Newswire - Tue Jul 15, 5:36PM CDT
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF" are investigating the proposed sale of Lorillard, Inc. ("Lorillard" or the "Company" (NYSE: LO) to Reynolds American Inc. ("Reynolds" (NYSE: RAI). Under the terms of the proposed transaction, shareholders of Lorillard will receive only $50.50 in cash and 0.2909 of a share of Reynolds stock for each share of Lorillard common stock that they own, implying a price of $68.88 per share of Lorillard based on Reynolds's closing share price on July 14, 2014. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

Is It Still Worth Betting on Big Tobacco?
Marshall Hargrave, The Motley Fool - Motley Fool - Tue Jul 15, 5:30PM CDT
The potential merger of the nation's second- and third-largest tobacco companies has been the hot topic among M&A speculators. Shares of Lorillard and Reynolds American have spiked on the news. Reynolds American is the second-largest...

Business Highlights
By The Associated Press - AP - Tue Jul 15, 5:00PM CDT
___

Why Lorillard Inc. Stock Got Smoked Today
Jeremy Bowman, The Motley Fool - Motley Fool - Tue Jul 15, 4:45PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What:  Shares of  Lorillard Inc. were taking a hit today,...

JPMorgan and Lorillard are big market movers
AP - Tue Jul 15, 3:44PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market:

Lorillard Falls 10.49% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Jul 15, 3:39PM CDT
Lorillard (NYSE:LO) traded in a range yesterday that spanned from a low of $59.66 to a high of $63.25. Yesterday, the shares fell 10.5%, which took the trading range below the 3-day low of $62.07 on volume of 32.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SmarTrend Watching for Potential Rebound in Shares of Lorillard After 10.49% Loss
Comtex SmarTrend(R) - Tue Jul 15, 3:38PM CDT
Lorillard (NYSE:LO) traded in a range yesterday that spanned from a low of $59.66 to a high of $63.25. Yesterday, the shares fell 10.5%, which took the trading range below the 3-day low of $62.07 on volume of 32.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Stock Market Today: Social Media, Biotech Suffer as Janet Yellen Shares Concerns on Valuation
at The Street - Tue Jul 15, 3:19PM CDT
Major indices trembled and the Nasdaq slid Tuesday following Fed Chair Janet Yellen's remarks on biotech and social media valuations.

Fitch Places Lorillard's Ratings on Negative Watch
Business Wire - Tue Jul 15, 2:21PM CDT
Fitch Ratings has placed Lorillard Inc.'s (Lorillard) 'BBB' Issuer Default Rating (IDR) on Rating Watch Negative. The rating action stems from Reynolds American Inc.'s (Reynolds) definitive agreement to acquire Lorillard for approximately $27.4 billion. The ratings apply to approximately $3.5 billion of Lorillard outstanding debt.

Reynolds American and Lorillard Merger Reshapes Tobacco Landscape
Ted Cooper, The Motley Fool - Motley Fool - Tue Jul 15, 2:15PM CDT
In a long-awaited announcement, Reynolds American finally disclosed that it would acquire Lorillard in a deal that has wide-ranging implications for the tobacco industry. Imperial Tobacco will acquire a number of brands as part of the deal,...


Tobacco firm Reynolds American to buy Lorillard
By MICHAEL FELBERBAUM - AP - Tue Jul 15, 2:13PM CDT
RICHMOND, Va. (AP) — Joe Camel is bulking up to take on the Marlboro Man.

Goldman Sachs, JPMorgan Earnings Beats Keep the Dow Afloat
Dan Carroll, The Motley Fool - Motley Fool - Tue Jul 15, 1:38PM CDT
The market has struggled to gain momentum today, and the Dow Jones Industrial Average has hovered around breakeven so far. As of 2:15 p.m. EDT, the Dow's hanging right above the breakeven mark, with its 30 member stocks split evenly between risers...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 160

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 125

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 116

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 221

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 96

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 137

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 167

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 135

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 253

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 44

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

We Energies Recognized for Exceptional Reliability Standards

Updated Category News Views 172

We Energies Celebrated for Excellence in Reliability MILWAUKEE / We Energies has recently been honored with the esteemed 2025 ReliabilityOne® Award, recognizing its superior performance in delivering reliable electric service. This accolade is a testament to the dedication and expertise of its workforce, as well as the strategic investments the company has made to...

Continue Reading
MicroStrategy Options Activity: Insights and Market Trends

Updated Category News Views 59

What Recent Options Activity Says About MicroStrategy Options flow often hints at how the crowd feels before price moves show it. Lately, the tone around MicroStrategy (MSTR) has leaned bearish, a point worth noting if you’re weighing your own trades. The signal isn’t subtle: activity has picked up sharply, and that surge alone can draw in traders who watch sentiment...

Continue Reading
Viactiv Expands Wellness Line with New Chews and Powder

Updated Category News Views 16

Viactiv Expands Beyond Calcium Forget just bone health; Viactiv is stepping up its game. They've gone beyond their trusty calcium chews with something new that targets women’s wellness in a broader sense. Meet the newcomers: Viactiv® CoQ10 CARDIO Complete Soft Chews and Viactiv® Magnesium Glycinate Powder. Ain't that a mouthful? But seriously, these are designed for...

Continue Reading
Rathbones Group Plc's Significant Position in Warpaint London

Updated Category News Views 107

Key Disclosure of Rathbones Group Plc In the financial landscape, transparency is of utmost importance, especially when significant interests in securities come to light. Rathbones Group Plc has provided a crucial disclosure as they maintain an interest in relevant securities of Warpaint London Plc, representing over 1% of their shares. This type of disclosure aligns with...

Continue Reading
Insights into Tryg A/S Q4 2024 Performance and Expectations

Updated Category News Views 260

Overview of Tryg A/S Q4 2024 Newsletter As the end of the year approaches, Tryg A/S is gearing up for a busy period of financial disclosures and investor engagement. In the week commencing mid-December, Tryg will conduct several pre-close analyst calls and meetings. This initiative is designed to prepare stakeholders ahead of the crucial Q4 2024 results release, which is...

Continue Reading